Stereotactic body radiation therapy for early-stage non–small-cell lung carcinoma: four-year results of a prospective phase II study

AJ Fakiris, RC McGarry, CT Yiannoutsos… - International Journal of …, 2009 - Elsevier
PURPOSE: The 50-month results of a prospective Phase II trial of stereotactic body radiation
therapy (SBRT) in medically inoperable patients are reported. METHODS AND MATERIALS …

Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications

A Chi, Z Liao, NP Nguyen, J Xu, B Stea… - Radiotherapy and …, 2010 - Elsevier
PURPOSE: To analyze the patterns of failure, the toxicity profile, and the factors influencing
efficacy of stereotactic body radiation (SBRT) for early-stage non-small-cell lung cancer …

[HTML][HTML] Stereotactic ablative body radiation therapy or surgery for operable early non-small cell lung cancer patients: bound hand and foot to evidence

A Levy, O Mercier, C Le Péchoux - Journal of Thoracic Disease, 2017 - ncbi.nlm.nih.gov
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2017; 9 (3): 482-484 jtd.
amegroups. com showed that occult node metastasis can occur in 5–10% of selected stage …

Stereotactic body radiation therapy versus nonradiotherapeutic ablative procedures (laser/cryoablation and electrocautery) for early-stage non–small cell lung cancer

MJ Baine, R Sleightholm, BK Neilsen… - Journal of the National …, 2019 - jnccn.org
Background: Despite the fact that stereotactic body radiation therapy (SBRT) is the only
recommended first-line therapy for inoperable early-stage non–small cell lung cancer …

[HTML][HTML] Stereotactic radiation for lung cancer: a practical approach to challenging scenarios

N Andruska, HB Stowe, C Crockett, W Liu… - Journal of Thoracic …, 2021 - Elsevier
Stereotactic body radiation therapy (SBRT) is an effective and well-tolerated treatment for
medically inoperable patients with early stage NSCLC. SBRT is a noninvasive treatment …

[HTML][HTML] Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold …

D Yalman, U Selek - Annals of Translational Medicine, 2015 - ncbi.nlm.nih.gov
The standard treatment for operable, early stage nonsmall cell lung cancer (NSCLC) is
surgical resection, usually lobectomy, with mediastinal lymph node sampling or dissection …

Stereotactic ablative radiation therapy for primary lung tumors

JH Heinzerling, B Kavanagh… - The Cancer Journal, 2011 - journals.lww.com
Stereotactic ablative radiotherapy, also known as stereotactic body radiation therapy, has
been developed as an innovative therapy for stage I non-small cell lung cancer and has now …

[HTML][HTML] Stereotactic Body Radiotherapy for Early-Stage Non–Small Cell Lung Cancer: When and Why Is It Appropriate Therapy?

K Mullins - Journal of the Advanced Practitioner in Oncology, 2015 - ncbi.nlm.nih.gov
Lung cancer, the second most frequently diagnosed malignancy for men and women in the
United States, will account for an estimated 221,200 newly diagnosed cases and 158,040 …

[HTML][HTML] SBRT in operable early stage lung cancer patients

J Roesch, N Andratschke… - Translational lung cancer …, 2014 - ncbi.nlm.nih.gov
Since decades the gold standard for treatment of early stage non-small cell lung cancer
(NSCLC) is surgical lobectomy plus mediastinal lymph node dissection. Patients in worse …

[HTML][HTML] Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?

AO Simeonova, K Fleckenstein, H Wertz… - … lung cancer research, 2012 - ncbi.nlm.nih.gov
In early stage non-small cell lung cancer (NSCLC) definitive radiation therapy is an
appropriate alternative to surgery. Recent studies show, that in such patients …